U
U.S. Stem Cell, Inc. USRM
$0.0001 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2022 09/30/2022 06/30/2022 03/31/2022 12/31/2021
Net Income 11.61% 15.91% 42.66% -17.96% -8.70%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 18.54% -9.44% -19.99% 18.58% -10.42%
Change in Net Operating Assets 92.11% 475.60% -94.50% 230.63% 6.90%
Cash from Operations 80.11% 68.59% 58.04% 79.91% -79.09%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued 14.71% -40.00% 503.50% -95.13% -73.60%
Total Debt Repaid 90.74% 87.07% 82.14% -45.28% -170.00%
Issuance of Common Stock -100.00% 0.00% -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -92.03% -14.13% 1,013.79% -94.77% 286.64%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -374.73% 118.40% 98.66% -105.85% 114.51%
Weiss Ratings